Last updated on November 2017

A study to evaluate the efficacy and safety of E2609 in individuals with early Alzheimer's disease


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Memory Loss | Alzheimer's Disease
  • Age: Between 55 - 85 Years
  • Gender: Male or Female

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.